GTDC1
tRNA-queuosine alpha-mannosyltransferase
Also known as: FLJ11753, Hmat-Xa, QTMAN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4AE62
- Gene
- GTDC1
- Ensembl
- ENSG00000121964
- Chromosome
- 2
- Canonical length
- 458 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables tRNA-queuosine(34) beta-mannosyltransferase activity. Involved in regulation of translation and tRNA modification. Located in nucleus. Is active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
458 residues, UniProt reviewed canonical sequence.
>Q4AE62|GTDC1
1 MSILIIEAFY GGSHKQLVDL LQEELGDCVV YTLPAKKWHW RARTSALYFS QTIPISEHYR
61 TLFASSVLNL TELAALRPDL GKLKKILYFH ENQLIYPVKK CQERDFQYGY NQILSCLVAD
121 VVVFNSVFNM ESFLTSMGKF MKLIPDHRPK DLESIIRPKC QVIYFPIRFP DVSRFMPKHK
181 TTHLKKMLGL KGNGGAVLSM ALPFQPEQRD SEDLLKNFNS ECDTHCGLDT ARQEYLGNSL
241 RQESDLKKST SSDNSSSHHG ENKQNLTVDP CDILGGVDNQ QRLLHIVWPH RWEHDKDPES
301 FFKVLMHLKD LGLNFHVSVL GETFTDVPDI FSEAKKALGS SVLHWGYLPS KDDYFQVLCM
361 ADVVISTAKH EFFGVAMLEA VYCGCYPLCP KDLVYPEIFP AEYLYSTPEQ LSKRLQNFCK
421 RPDIIRKHLY KGEIAPFSWA ALHGKFRSLL TTEPREDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GTDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 18 nTPM
- cerebral cortex: 17 nTPM
- heart muscle: 16 nTPM
- adipose tissue: 15 nTPM
- amygdala: 15 nTPM
- bone marrow: 15 nTPM
Single-cell type
- neutrophils: 1,273 nCPM
- neutrophil progenitors: 506 nCPM
- oligodendrocytes: 448 nCPM
- podocytes: 351 nCPM
- oligodendrocyte progenitor cells: 295 nCPM
- myosatellite cells: 255 nCPM
Immune cell
- MAIT T-cell: 16 nTPM
- neutrophil: 14 nTPM
- memory CD8 T-cell: 12 nTPM
- NK-cell: 12 nTPM
- eosinophil: 10 nTPM
- gdT-cell: 7.5 nTPM
Brain region
- white matter: 58 nTPM
- cerebral cortex: 50 nTPM
- spinal cord: 44 nTPM
- basal ganglia: 43 nTPM
- hippocampal formation: 41 nTPM
- amygdala: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.15
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
OntologyGO
Biological processes
Molecular functions
- tRNA-queuosine(34) beta-mannosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycosyl transferase, family 1
- Glycosyl transferases group 1
- tRNA-queuosine alpha-mannosyltransferase, N-terminal
- Glycosyltransferase-like domain-containing protein 1
- tRNA-queuosine alpha-mannosyltransferase N-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GTDC1 as an antibody target. Whether an autoantibody or antibody against GTDC1 could matter depends on whether native GTDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GTDC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GTDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...